KARI MASSEY: Open Payments
NPI 1104396696 · TENAHA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$328 in 12 payments from 7 companies in 2025. Trend: 2023 $47 · 2024 $425 · 2025 $328
Food & beverage: $328
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $158 |
| Exact Sciences Corporation | 2 | $34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| PFIZER INC. | 2 | $30 |
| GlaxoSmithKline, LLC. | 1 | $29 |
| Dexcom, Inc. | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
Products named: CAPLYTA, The Cologuard Plus Collection Kit, XIFAXAN, TRELEGY ELLIPTA, Dexcom G6 Transmitter, FARXIGA, PAXLOVID, ELIQUIS.
Industry payments across TX — which companies pay providers there.
